相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effects in vivo in a mouse model of hypertrophic cardiomyopathy
Frederik Flenner et al.
CARDIOVASCULAR RESEARCH (2016)
Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca2+-sensitivity and suppress the modulation of Ca2+-sensitivity by troponin I phosphorylation
Andrew E. Messer et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2016)
Novel Potential Treatment of Familial Hypertrophic Cardiomyopathy with Analogues of the Green Tea Polyphenol Epigallocatechin-3-Gallate
Paul J. Robinson et al.
BIOPHYSICAL JOURNAL (2016)
Genetic advances in sarcomeric cardiomyopathies: state of the art
Carolyn Y. Ho et al.
CARDIOVASCULAR RESEARCH (2015)
Targets for therapy in sarcomeric cardiomyopathies
Jil C. Tardiff et al.
CARDIOVASCULAR RESEARCH (2015)
Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy-Associated Mutation in Human Cardiac Troponin I (K206I)
Chad M. Warren et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
High Concentration of Epigallocatechin-3-Gallate Increased the Incidences of Arrhythmia and Diastolic Dysfunction Via β2-adrenoceptor
Lei Bao et al.
JOURNAL OF FOOD SCIENCE (2015)
The E3 ubiquitin ligase Asb2β is downregulated in a mouse model of hypertrophic cardiomyopathy and targets desmin for proteasomal degradation
Tilo Thottakara et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy-Associated Mutation in Human Cardiac Troponin I (K206I)
Chad M. Warren et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
Genetics of Hypertrophic and Dilated Cardiomyopathy
Felix W. Friedrich et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2015)
Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice
Aref Najafi et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2015)
Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy
David Barefield et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
FHL2 expression and variants in hypertrophic cardiomyopathy
Felix W. Friedrich et al.
BASIC RESEARCH IN CARDIOLOGY (2014)
Desensitization of Myofilaments to Ca2+ as a Therapeutic Target for Hypertrophic Cardiomyopathy With Mutations in Thin Filament Proteins
Marco L. Alves et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2014)
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
Perry M. Elliott et al.
EUROPEAN HEART JOURNAL (2014)
Hypertrophic Cardiomyopathy Present and Future, With Translation Into Contemporary Cardiovascular Medicine
Barry J. Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice
Giulia Mearini et al.
NATURE COMMUNICATIONS (2014)
Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy
Saskia Schlossarek et al.
FRONTIERS IN PHYSIOLOGY (2014)
Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in mice
Christina Gedicke-Hornung et al.
EMBO MOLECULAR MEDICINE (2013)
Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice
Andrea Stoehr et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Repair of Mybpc3 mRNA by 5′-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy
Giulia Mearini et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy
Saskia Schlossarek et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
Understanding Cardiomyopathy Phenotypes Based on the Functional Impact of Mutations in the Myosin Motor
Jeffrey R. Moore et al.
CIRCULATION RESEARCH (2012)
Contractile Dysfunction Irrespective of the Mutant Protein in Human Hypertrophic Cardiomyopathy With Normal Systolic Function
Sabine J. van Dijk et al.
CIRCULATION-HEART FAILURE (2012)
Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis
Markus Brueckner et al.
JOURNAL OF CROHNS & COLITIS (2012)
Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice
Bodvael Fraysse et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice
Henrik Ortsater et al.
NUTRITION & METABOLISM (2012)
Coordinated Regulation of Murine Cardiomyocyte Contractility by Nanomolar (-)-Epigallocatechin-3-Gallate, the Major Green Tea Catechin
Wei Feng et al.
MOLECULAR PHARMACOLOGY (2012)
Epigallocatechin-3-gallate has dual, independent effects on the cardiac sarcoplasmic reticulum/endoplasmic reticulum Ca2+ ATPase
M. E. Kargacin et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2011)
The green tea polyphenol (-)-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis
Ai Peng et al.
KIDNEY INTERNATIONAL (2011)
Biological actions of green tea catechins on cardiac troponin C
Naoto Tadano et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Molecular basis of hereditary cardiomyopathy: abnormalities in calcium sensitivity, stretch response, stress response and beyond
Akinori Kimura
JOURNAL OF HUMAN GENETICS (2010)
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility
Sabine Huke et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Cardiac Myosin-Binding Protein C Mutations and Hypertrophic Cardiomyopathy Haploinsufficiency, Deranged Phosphorylation, and Cardiomyocyte Dysfunction
Sabine J. van Dijk et al.
CIRCULATION (2009)
Nonsense-Mediated mRNA Decay and Ubiquitin-Proteasome System Regulate Cardiac Myosin-Binding Protein C Mutant Levels in Cardiomyopathic Mice
Nicolas Vignier et al.
CIRCULATION RESEARCH (2009)
Solution Structure of Human Cardiac Troponin C in Complex with the Green Tea Polyphenol, (-)-Epigallocatechin 3-Gallate
Ian M. Robertson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Left Atrial Volume Index: A Predictor of Adverse Outcome in Patients With Hypertrophic Cardiomyopathy
Woo-In Yang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2009)
Positive inotropic effects of epigallocatechin-3-gallate (EGCG) involve activation of Na+/H+ and Na+/Ca2+ exchangers
Mario Lorenz et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice
Franz Baudenbacher et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
From genotype to phenotype: a longitudinal study of a patient with hypertrophic cardiomyopathy due to a mutation in the MYBPC3 gene
Adam Jacques et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2008)
Differential effects of a green tea-derived polyphenol (-)-epigallocatechin-3-gallate on the acidosis-induced decrease in the Ca2+ sensitivity of cardiac and skeletal muscle
Ying-Ming Liou et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2008)
Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils
Bogdan Iorga et al.
CARDIOVASCULAR RESEARCH (2008)
Dilated and hypertrophic cardiomyopathy mutations in troponin and α-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments
Paul Robinson et al.
CIRCULATION RESEARCH (2007)
Cardiac myosin-binding protein c is required for complete relaxation in intact myocytes
Lutz Pohlmann et al.
CIRCULATION RESEARCH (2007)
Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis
Ganapathy Jagatheesan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure
Ali El-Armouche et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Molecular targets of tea polyphenols in the cardiovascular system
Verena Stangl et al.
CARDIOVASCULAR RESEARCH (2007)
A molecular screening strategy based on β-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy
Francesca Girolami et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2006)
Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta
E Alvarez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice
O Cazorla et al.
CARDIOVASCULAR RESEARCH (2006)
The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells
A Ludwig et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation
M Lorenz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice
KY Chyu et al.
CIRCULATION (2004)
Hypertrophic cardiomyopathy - Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy
P Richard et al.
CIRCULATION (2003)
Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy
BC Knollmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
